TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Bio Forte AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
13,880
|
14,920
|
15,127 |
Financial expenses |
8
|
7
![]() |
7 |
Earnings before taxes |
486
|
418
|
958 |
Total assets |
4,587
|
4,558
|
4,169 |
Current assets |
4,259
|
4,022
|
3,923 |
Current liabilities |
1,266
|
1,401
|
1,420 |
Equity capital |
3,322
|
3,151
|
2,742 |
- share capital |
197
|
211
|
205 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.4%
|
69.1%
|
65.8% |
Turnover per employee | |||
Profit as a percentage of turnover |
3.5%
|
2.8%
|
6.3% |
Return on assets (ROA) |
10.8%
|
9.3%
|
23.1% |
Current ratio |
336.4%
|
287.1%
|
276.3% |
Return on equity (ROE) |
14.6%
|
13.3%
|
34.9% |
Change turnover |
-51
|
-676
|
-1,710 |
Change turnover % |
0%
|
-4%
|
-10% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.